Results 31 to 40 of about 1,122,058 (270)

Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression

Journal of Parkinson’s Disease, 2023
Background: Identifying a meaningful progression metric for Parkinson’s disease (PD) that reflects heterogeneity remains a challenge. Objective: To assess the frequency and baseline predictors of progression to clinically relevant motor and non-motor PD ...
Michael C. Brumm, Andrew Siderowf, Tanya Simuni, Elliot Burghardt, Seung Ho Choi, Chelsea Caspell-Garcia, Lana M. Chahine, Brit Mollenhauer, Tatiana Foroud, Douglas Galasko, Kalpana Merchant, Vanessa Arnedo, Samantha J. Hutten, Alyssa N. O’Grady, Kathleen L. Poston, Caroline M. Tanner, Daniel Weintraub, Karl Kieburtz, Kenneth Marek, Christopher S. Coffey,   +20 more
doaj   +1 more source

Motor developmental milestones in connection with coordination [PDF]

, 2023
Namen diplomskega dela z naslovom Mejniki gibalnega razvoja v povezavi s koordinacijo je bil ugotoviti, kdaj so otroci dosegali mejnike gibalnega razvoja in kakšna je povezava med doseganjem mejnikov gibalnega razvoja ter razvitostjo koordinacije ...
Zelenik, Anja
core  

Effect of MMS and LNS on time to achievement of the WHO gross motor milestones as compared to IFA.

, 2022
Effect of MMS and LNS on time to achievement of the WHO gross motor milestones as compared to IFA.
Ousmane Guindo (35279), Lilia Bliznashka (11442539), Céline Langendorf (624676), Christopher R. Sudfeld (7372553), Issaka Soumana (11067907), Rebecca F. Grais (8151654), Aichatou Salifou (12488345), Irène Adehossi (12488348), Sheila Isanaka (323429)   +8 more
core   +1 more source

Clinical classification systems and long-term outcome in mid- and late-stage Parkinson’s disease

npj Parkinson's Disease, 2021
Parkinson’s disease shows a heterogeneous course and different clinical subtyping systems have been described. To compare the capabilities of two clinical classification systems, motor-phenotypes, and a simplified clinical motor-nonmotor subtyping system,
Emil Ygland Rödström, Andreas Puschmann   +1 more
doaj   +1 more source

Impact of Neonatal Body (Dis)Proportionality Determined by the Cephalization Index (CI) on Gross Motor Development in Children with Down Syndrome: A Prospective Cohort Study

Children, 2022
Background: Children with Down syndrome (DS) lag behind typical children in the acquisition of developmental milestones, which could differ depending on body proportionality.
Asija Rota Čeprnja, Shelly Melissa Pranić, Martina Šunj, Tonći Kozina, Joško Božić, Slavica Kozina   +5 more
doaj   +1 more source

Developmental Milestones of Infancy and Associations with Later Childhood Neurodevelopmental Outcomes in the Adolescent Brain Cognitive Development (ABCD) Study

Children, 2022
The age at attaining infancy developmental milestones has been associated with later neurodevelopmental outcomes, but evidence from large and diverse samples is lacking.
Haoran Zhuo, Jingyuan Xiao, Wan-Ling Tseng, Zeyan Liew   +3 more
doaj   +1 more source

Development of Clinical Milestones in Parkinson’s Disease After Bilateral Subthalamic Deep Brain Stimulation [PDF]

Journal of Movement Disorders, 2022
Objective Deep brain stimulation of the subthalamic nucleus (STN-DBS) in Parkinson’s disease (PD) patients does not halt disease progression, as these patients will progress and develop disabling non-levodopa responsive symptoms.
Jed Noel A. Ong, Jung Hwan Shin, Seungho Jeon, Chan Young Lee, Han-Joon Kim, Sun Ha Paek, Beomseok Jeon   +6 more
doaj   +1 more source

Similarities and differences in child development from birth to age 3 years by sex and across four countries: a cross-sectional, observational study

The Lancet Global Health, 2018
Summary: Background: Knowledge about typical development is of fundamental importance for understanding and promoting child health and development. We aimed to ascertain when healthy children in four culturally and linguistically different countries ...
Ilgi Ozturk Ertem, ProfMD, Vibha Krishnamurthy, MD, Mphelekedzeni C Mulaudzi, MD, Yanina Sguassero, MD, Hakan Balta, MD, Ozlem Gulumser, MD, Burcu Bilik, MSc, Roopa Srinivasan, MD, Benjamin Johnson, MSc, Geliang Gan, PhD, Lisa Calvocoressi, PhD, Veronika Shabanova, PhD, Brian W C Forsyth, ProfMBChB   +12 more
doaj   +1 more source

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan. [PDF]

Ann Clin Transl Neurol
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Saito K, Benguerba K, Tsuchida K, Yazawa K, Tsumiyama I, Kayama H, Reyna SP, Khan F, Finkel RS.   +8 more
europepmc   +2 more sources

Evidence-Based Milestones for Surveillance of Cognitive, Language, and Motor Development [PDF]

Academic Pediatrics, 2013
Fewer than half of the nation's pediatricians conduct systematic surveillance of young children's development. Because time and cost are among the barriers, our objective was to create a brief set of parent-report questions about cognitive, motor, and language milestones that is freely available and can be administered and scored quickly.A team of ...
R Christopher, Sheldrick, Ellen C, Perrin   +1 more
openaire   +2 more sources